Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announces that it has acquired Biolife Delaware, L.L.C. (“Biolife”) in a merger transaction through which Biolife has become a wholly-owned subsidiary of Merit. Biolife, which is headquartered in Sarasota, Florida, manufactures unique patented hemostatic devices under the brand names StatSeal and WoundSeal. The aggregate transaction consideration, paid in cash and assumption of Biolife liabilities, was approximately $120 million. This strategic acquisition positions Merit to provide clinicians with more products designed to standardize, simplify, and minimize post-procedure care and maintenance.
Read the full article: Merit Medical Acquires Biolife Delaware, L.L.C. //
Source: https://www.globenewswire.com/news-release/2025/05/20/3084740/8028/en/Merit-Medical-Acquires-Biolife-Delaware-L-L-C.html